Apollomics Inc. Warrant (APLMW) is a Healthcare · Biotechnology company listed on NASDAQ. Price $0.01 (+0.08%), Market cap $0.04B, 52-week low–high $0.01 ~ $0.03.
Apollomics, Inc., a biotechnology company, engages in the discovery and development of mono and combination oncology therapies to harness the immune system and target specific molecular pathways to inhibit cancer. Its pipeline consists of various development-stage assets, including novel and humanized monoclonal antibodies that restore the body's immune system to recognize and kill cancer cells, and targeted therapies against uncontrolled growth signaling pathways. Its solutions include tumor inhibitors, anti-cancer enhancers, and immune-oncology drugs. Apollomics, Inc. was formerly known as CBT Pharmaceuticals, Inc. and changed its name to Apollomics, Inc. in January 2019. Apollomics, Inc.
Financial statements, price targets, institutional (13F) holdings and related news for Apollomics Inc. Warrant are updated in real time on BlackAll Trade.
Apollomics Inc. Warrant trades at $0.01 (+0.08%). Real-time quotes and charts are available on BlackAll Trade.
Apollomics Inc. Warrant has a market cap of about $0.04B.
Apollomics, Inc., a biotechnology company, engages in the discovery and development of mono and combination oncology therapies to harness the immune system and target specific molecular pathways to in